Invitrogen™ Human DRAK1 Synthetic Peptide

Ref.: BL-RE-175992Manufacturer ref.: PEP-0051 50 μg
€149.00 excl. VAT

DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.

Gene ID (Enter)
9263
Species
Human
Purification method
Purified
Accession number
Q9UEE5
Common name
Human DRAK1
Brand
Invitrogen

DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.

DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.

STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15246279
Specifications
Gene ID (Enter)9263
SpeciesHuman
Purification methodPurified
Accession numberQ9UEE5
Common nameHuman DRAK1
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)STK17A
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0051
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.